Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 7
Submit an article Journal homepage
916
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Meeting Report

9th Immunotherapy of Cancer conference (ITOC): A meeting report

Iman Dalloula Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Member of the German Center for Lung Research (DZL), Munich, GermanyView further author information
,
Thaddäus Jan Clemens Strzalkowskia Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Member of the German Center for Lung Research (DZL), Munich, GermanyView further author information
,
Michael von Bergwelt-Baildonb German Center for Translational Cancer Research (DKTK), partner site Munich, Germany;c Department of Medicine III, University Hospital, Ludwig-Maximilians-Universität München, Munich, GermanyView further author information
,
Volkmar Nüsslerd Tumorzentrum München, Munich, GermanyView further author information
,
Christoph Zielinskie Central European Cooperative Oncology Group (CECOG), Wiener Privatklinik, Vienna, AustriaView further author information
&
Sebastian Kobolda Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Member of the German Center for Lung Research (DZL), Munich, Germany;b German Center for Translational Cancer Research (DKTK), partner site Munich, Germany;f Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, Germany;g Research Center for Environmental Health (HMGU), Neuherberg, GermanyCorrespondence[email protected]
View further author information
Article: 2159706 | Received 17 Nov 2022, Accepted 08 Dec 2022, Published online: 28 Dec 2022

References

  • Kobold S, Krackhardt A, Schlösser H, Wolf D. Immuno-oncology: a brief overview. Dtsch Med Wochenschr. 2018;143(14):1006–5. doi:10.1055/a-0623-9147.
  • Kobold S, Duewell P, Schnurr M, Subklewe M, Rothenfusser S, Endres S. Immunotherapy in tumors. Dtsch Arztebl Int. 2015;112:809–15. doi:10.3238/arztebl.2015.0809.
  • Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, Schuebbe G, Renz BW, D’Haese JG, Schloesser H, et al. Advances in cancer immunotherapy 2019 – latest trends. J Exp Clin Cancer Res. 2019;38(1):268. doi:10.1186/s13046-019-1266-0.
  • Umut Ö, Gottschlich A, Endres S, Kobold S. CAR T cell therapy in solid tumors: a short review. Memo. 2021;14(2):143–49. doi:10.1007/s12254-021-00703-7.
  • Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–55. doi:10.1126/science.aar4060.
  • Lesch S, Benmebarek M-R, Cadilha BL, Stoiber S, Subklewe M, Endres S, Kobold S. Determinants of response and resistance to CAR T cell therapy. Semin Cancer Biol. 2020;65:80–90. doi:10.1016/j.semcancer.2019.11.004.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.